A

B

ANACLERICO , Barbara

Last name: ANACLERICO

First name: Barbara

2017 (v1)

Publication

Metadata-only

Baseline factors associated with response to ruxolitinib: An independent study on 408 patients with myelofibrosis

Palandri, Francesca Palumbo, Giuseppe Alberto Bonifacio, Massimiliano

In patients with Myelofibrosis (MF) treated with ruxolitinib (RUX), the response is unpredictable at therapy start. We retrospectively evaluated the impact of clinical/laboratory factors on responses in 408 patients treated with RUX according to prescribing obligations in 18 Italian Hematology Centers. At 6 months, 114 out of 327 (34.9%)...

Uploaded on: April 14, 2023